News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,525 Results
Type
Article (41611)
Company Profile (259)
Press Release (665655)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (206392)
Career Advice (2038)
Deals (35735)
Drug Delivery (95)
Drug Development (81428)
Employer Resources (172)
FDA (16313)
Job Trends (15053)
News (348633)
Policy (33003)
Tag
Academia (2636)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50258)
ALS (88)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (124)
Approvals (16317)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (364)
Best Places to Work (11708)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2267)
Cardiovascular disease (179)
Career advice (1706)
Career pathing (31)
CAR-T (151)
Cell therapy (424)
Cervical cancer (20)
Clinical research (66183)
Collaboration (839)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2639)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2209)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (271)
Diagnostics (6541)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87087)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (113221)
Executive appointments (726)
FDA (17578)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (758)
Gene editing (106)
Generative AI (19)
Gene therapy (304)
GLP-1 (721)
Government (4466)
Grass and pollen (4)
Guidances (67)
Healthcare (18955)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2784)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16581)
IRA (40)
Job creations (3753)
Job search strategy (1450)
Kidney cancer (10)
Labor market (38)
Layoffs (471)
Leadership (18)
Legal (8030)
Liver cancer (75)
Lung cancer (323)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (68)
Medical device (13445)
Medtech (13450)
Mergers & acquisitions (19700)
Metabolic disorders (689)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1927)
NextGen: Class of 2025 (6551)
Non-profit (4539)
Now hiring (39)
Obesity (366)
Opinion (207)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (47)
People (57962)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20634)
Phase II (29120)
Phase III (21710)
Pipeline (1208)
Policy (139)
Postmarket research (2584)
Preclinical (8856)
Press Release (67)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (379)
Real estate (6123)
Recruiting (65)
Regulatory (22590)
Reports (46)
Research institute (2382)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (132)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3621)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (693)
Venture capitalists (41)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Last 7 days (899)
Last 30 days (2474)
Last 365 days (32767)
2025 (10789)
2024 (35421)
2023 (40334)
2022 (51428)
2021 (56014)
2020 (54501)
2019 (46978)
2018 (35339)
2017 (32516)
2016 (31984)
2015 (38008)
2014 (31867)
2013 (26991)
2012 (29105)
2011 (29781)
2010 (27823)
Location
Africa (734)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (38663)
Australia (6328)
California (6156)
Canada (2027)
China (526)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (83319)
Florida (913)
Georgia (207)
Idaho (57)
Illinois (538)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (900)
Massachusetts (4581)
Michigan (220)
Minnesota (395)
Mississippi (2)
Missouri (87)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1735)
New Mexico (29)
New York (1753)
North Carolina (986)
North Dakota (8)
Northern California (2685)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1126)
South Carolina (23)
South Dakota (1)
Southern California (2315)
Tennessee (101)
Texas (913)
United States (23238)
Utah (182)
Virginia (146)
Washington D.C. (62)
Washington State (554)
West Virginia (3)
Wisconsin (55)
707,525 Results for "watson laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
LenioBio Appoints Hugh Watson as Chief Financial Officer
LenioBio announced the appointment of Hugh Watson as its new Chief Financial Officer, effective January 1, 2024.
January 11, 2024
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
Biotech Bay
bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
bioLytical Laboratories Inc., a global leader in rapid diagnostic tests, proudly announces the immediate availability of its INSTI® HCV Antibody Test in the Australian market.
May 19, 2024
·
4 min read
Press Releases
STELLUS CAPITAL MANAGEMENT, LLC PROVIDES UNITRANCHE FINANCING IN SUPPORT OF NORTHLANE CAPITAL PARTNERS’ INVESTMENT IN UNITED STATES DRUG TESTING LABORATORIES INC.
January 28, 2025
·
1 min read
BioMidwest
Kraig Biocraft Laboratories Increases Spider Silk Production with Next Generation of Hybrid Eggs Completed
Kraig Biocraft Laboratories, Inc., announces that it has expanded its production of spider silk with the creation of the next generation of BAM-1 hybrid.
June 25, 2024
·
2 min read
Press Releases
Open Healthcare Inc. Expands U.S. Operations With CTON Laboratory Acquisition, New Facility in Gardena, and Appointment of New COO
December 23, 2024
·
3 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
Mesa Laboratories, Inc. will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 31, 2024.
May 22, 2024
·
1 min read
1 of 70,753
Next
